Pharma News, Research & Solutions CSR News

Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience

Summary: 

-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I Disorder --

-- Five Additional Poster Presentations Highlight Data Related to ALKS 3831 and ARISTADA® --

Press Release

-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I Disorder --

-- Five Additional Poster Presentations Highlight Data Related to ALKS 3831 and ARISTADA® --

Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine

In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
Article

Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approvals of the first vaccines for COVID-19.

The Road to a Vaccine, Season 2, Ep. 5: What Have We Learned After Eight Months of COVID-19?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 5, Lisa Ling asks health experts for a pandemic status report, including the latest statistics on cases worldwide, the current thinking about coronavirus and its effects and what’s working to fight the disease—and what’s not.

4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s

Summary: 

From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.

Article

From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.

The Road to a Vaccine: Why Does COVID-19 More Greatly Affect Communities of Color?

Multimedia with summary

In this bonus clip from “The Road to a Vaccine,” health experts explain why communities of color in the U.S. are disproportionately affected by COVID-19—and how to help solve this glaring disparity.

Be sure to tune in for the next live episode, returning September 8 at 12 PM ET.

The Road to a Vaccine, Season 2, Ep. 4: How Healthcare Advocates Are Changing the Global Conversation About COVID-19

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

Alexion Joins the Covid Alliance to Support Testing in Ireland

Blog

The COVID-19 pandemic has had a profound impact on the lives of people all around the world, inspiring individuals and companies alike to step up and serve their communities in more ways than ever before.

The Road to a Vaccine, Season 2, Ep. 3: How Is COVID-19 Affecting Children? What Parents Worldwide Should Know

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 3, Lisa Ling talks to UNICEF’s Henrietta Fore about global efforts to get all kids vaccinated. Harvard's Dr. Vikram Patel discusses children’s mental health during the pandemic. Plus, parents ask the experts their pressing questions about COVID-19.

Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

Summary: 

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.

Article

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.

Coronavirus: Opportunity for a New Health Paradigm

Multimedia with summary

The coronavirus pandemic has humbled humanity and shed light on the fragility of the world and the health systems built to deliver care. At the same time, rapid advances in technology and medical science have shown potential new paths forward to building a healthier future.

With its rich health data and global leadership in technology, life sciences, and precision manufacturing, Japan has the capacity to play a leading role in designing a new health paradigm.

Pages

Subscribe to Pharma News, Research & Solutions